Duncker Streett & Co. Inc. Sells 192 Shares of Colgate-Palmolive (NYSE:CL)

Duncker Streett & Co. Inc. reduced its position in Colgate-Palmolive (NYSE:CL) by 1.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 14,723 shares of the company’s stock after selling 192 shares during the quarter. Duncker Streett & Co. Inc.’s holdings in Colgate-Palmolive were worth $1,174,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Vest Financial LLC grew its holdings in shares of Colgate-Palmolive by 25.1% during the 4th quarter. Vest Financial LLC now owns 370,071 shares of the company’s stock valued at $29,498,000 after purchasing an additional 74,337 shares during the last quarter. Central Bank & Trust Co. grew its holdings in shares of Colgate-Palmolive by 22.1% during the 4th quarter. Central Bank & Trust Co. now owns 1,383 shares of the company’s stock valued at $110,000 after purchasing an additional 250 shares during the last quarter. Dynamic Advisor Solutions LLC grew its holdings in shares of Colgate-Palmolive by 9.2% during the 4th quarter. Dynamic Advisor Solutions LLC now owns 10,808 shares of the company’s stock valued at $864,000 after purchasing an additional 910 shares during the last quarter. Sarasin & Partners LLP grew its holdings in shares of Colgate-Palmolive by 1.2% during the 4th quarter. Sarasin & Partners LLP now owns 4,053,634 shares of the company’s stock valued at $323,115,000 after purchasing an additional 49,980 shares during the last quarter. Finally, Cornerstone Wealth Management LLC grew its holdings in shares of Colgate-Palmolive by 2.5% during the 4th quarter. Cornerstone Wealth Management LLC now owns 7,170 shares of the company’s stock valued at $571,000 after purchasing an additional 172 shares during the last quarter. 80.41% of the stock is owned by institutional investors.

Colgate-Palmolive Price Performance

Shares of Colgate-Palmolive stock remained flat at $86.17 during trading on Wednesday. 3,220,548 shares of the company were exchanged, compared to its average volume of 3,530,158. The company has a market cap of $70.83 billion, a price-to-earnings ratio of 30.99, a PEG ratio of 3.28 and a beta of 0.42. The company has a fifty day moving average price of $86.92 and a 200 day moving average price of $80.58. The company has a quick ratio of 0.71, a current ratio of 1.11 and a debt-to-equity ratio of 8.59. Colgate-Palmolive has a 52 week low of $67.62 and a 52 week high of $90.37.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, January 26th. The company reported $0.87 EPS for the quarter, beating the consensus estimate of $0.85 by $0.02. Colgate-Palmolive had a net margin of 11.82% and a return on equity of 509.75%. The business had revenue of $4.95 billion for the quarter, compared to the consensus estimate of $4.89 billion. During the same period in the prior year, the firm earned $0.77 earnings per share. The company’s revenue was up 6.9% compared to the same quarter last year. Equities research analysts expect that Colgate-Palmolive will post 3.49 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Monday, April 22nd will be issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.32%. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.48. The ex-dividend date is Friday, April 19th. Colgate-Palmolive’s dividend payout ratio is presently 69.06%.

Insider Transactions at Colgate-Palmolive

In related news, Director C Martin Harris sold 2,760 shares of the company’s stock in a transaction that occurred on Wednesday, January 31st. The shares were sold at an average price of $84.50, for a total value of $233,220.00. Following the transaction, the director now directly owns 19,272 shares in the company, valued at $1,628,484. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In related news, Director C Martin Harris sold 2,760 shares of the company’s stock in a transaction that occurred on Wednesday, January 31st. The shares were sold at an average price of $84.50, for a total value of $233,220.00. Following the transaction, the director now directly owns 19,272 shares in the company, valued at $1,628,484. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Noel R. Wallace sold 50,000 shares of the firm’s stock in a transaction that occurred on Monday, February 12th. The stock was sold at an average price of $83.15, for a total transaction of $4,157,500.00. Following the completion of the transaction, the chief executive officer now owns 274,179 shares in the company, valued at approximately $22,797,983.85. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 232,371 shares of company stock valued at $19,505,099. 0.37% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several research firms recently commented on CL. JPMorgan Chase & Co. lifted their target price on shares of Colgate-Palmolive from $88.00 to $90.00 and gave the stock an “overweight” rating in a research report on Thursday, January 18th. The Goldman Sachs Group began coverage on shares of Colgate-Palmolive in a research report on Friday, March 1st. They set a “buy” rating and a $93.00 target price on the stock. Stifel Nicolaus lifted their target price on shares of Colgate-Palmolive from $89.00 to $94.00 and gave the stock a “buy” rating in a research report on Wednesday, April 10th. StockNews.com downgraded shares of Colgate-Palmolive from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, February 20th. Finally, Raymond James upgraded shares of Colgate-Palmolive from a “market perform” rating to an “outperform” rating and set a $91.00 target price on the stock in a research report on Monday, January 29th. Three investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $89.50.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.